Friday, September 30, 2022


Biotechnology News Magazine

Terumo Launches Global Therapeutic Interventional Oncology Team: Effective April 1, 2021

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

April 12, 2021

Terumo is building a Global Therapeutic Interventional Oncology team to offer more therapeutic solution to cancer patients.

This reflects Terumo’s aspiration to be a Global leader in the field of Interventional Oncology by focusing on improving patient’s quality of life and survival.

This organization will be comprised of Medical Strategy, Research & Development, Software Development, Medical Imaging Discovery, and Operations. It will be entirely dedicated to the development of Therapeutic Interventional Oncology solutions for patients with cancer. This team will be led by Laurent Domas, Vice President, Global Interventional Oncology Strategy and Therapy Development.

“With this team of specialists, we want to provide excellence in developing Interventional Oncology solutions to improve the clinical benefit for patients with cancer, and thus contribute to society through healthcare”, said Laurent Domas.

Terumo Interventional Systems is a leader in access technologies used in Interventional Oncology procedures and already offers a broad range of therapeutic solutions in EMEA. The Therapeutic Interventional Oncology portfolio comprises drug eluting microspheres with LifePearlTM microspheres, Selective Internal Radiation Therapy solutions with the Holmium platform (QuiremSpheresTM microspheres, QuiremScoutTM microspheres, QSuiteTM software) and Thermal Microwave ablation with TATO*.

The need for minimally invasive cancer treatments is growing to address the continuous rise of cancer in a global aging population. Terumo aims at being a major player in Interventional Oncology by facilitating access to loco-regional treatments for patients with cancer by focusing on innovation and clinical evidence and partnering with Health Care Professionals.

“It is excellent news to see, within Terumo, the launch of a Therapeutic Interventional Oncology focused team, which is a dedicated entity that will help moving fast forward in the booming and promising field of interventional oncology”, said Professor Thierry De Baère, head of Therapeutic Imaging department, Gustave Roussy Institute, Villejuif, France

With this organization in place, Terumo Interventional Systems will accelerate the commercial deployment of the Holmium platform (QuiremSpheresTM microspheres, QuiremScoutTM microspheres, QSuiteTM software) in EMEA. It will further extend the availability of the Holmium platform in other regions, in particular US as the largest radioembolization market but also China and other countries around the globe.

The creation of the Global Therapeutic Interventional Oncology organization will contribute to complete Terumo Interventional Systems’ portfolio of solutions for the treatment of cancers in the liver and in other organs. In particular, it currently investigates the development of radiation oncology technologies for the treatment of pancreatic tumors. It will also innovate in new targeted drug delivery solutions.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine